Newborn screening for congenital hypothyroidism (CH) is based on testing for the markers thyroxine (T4) and/or thyroid-stimulating hormone (TSH). Diagnosis of CH is complicated because many factors affect the levels of these hormones including infant birth weight, prematurity and age at specimen collection. We investigated whether the sex of the newborn affected the levels of T4 and TSH and consequently the outcome of newborn screening.
In New York State, the Newborn Screening program initially tests all infants for T4 and any baby with a result in the lowest 10% is triaged for TSH screening. We analyzed data from 2008 to 2016 to determine mean and median T4 and TSH values and how these results correlate with the sex of infants who are reported as borderline, referred and confirmed with CH.
T4 and TSH concentrations in dried blood spots were measured using commercially available fluoroimmunoassays.
From 2008 to 2016, of the 2.4 million specimens tested for thyroxine, 51.5% were from male and 48.5% were from female infants. Male infants constituted 60% of specimens triaged for TSH testing, 64.9% of repeat requests and 59.6% of referrals, but only 49% of confirmed CH cases. The mean and median T4 values were lower (a difference of approximately 0.8–1.1 μg/dL each year) and the median TSH values were higher in male compared to female infants.
Natural differences in thyroid hormone levels in male and female infants leads to male infants being disproportionately represented in the false-positive category.
American Academy of PediatricsRoseSRBrownRSFoleyTKaplowitzPBKayeCIet al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics20061172290–2303. (https://doi.org/10.1542/peds.2006-0915)
FordGLaFranchiSH.Screening for congenital hypothyroidism: a worldwide view of strategies. Best Practice and Research Clinical Endocrinology and Metabolism201428175–187. (https://doi.org/10.1016/j.beem.2013.05.008)
KawaharaKYokoyaS.Original establishment of reference intervals of thyrotropin and free thyroid hormones during the first week of life. Clinical Pediatric Endocrinology2002111–9. (https://doi.org/10.1297/cpe.11.1)
HymanSJNovoaYHolzmanI.Perinatal endocrinology: common endocrine disorders in the sick and premature newborn. Pediatric Clinics of North America2011581083–1098. (https://doi.org/10.1016/j.pcl.2011.07.003)
CarrascosaARuiz-CuevasPPotauNAlmarJSalcedoSClementeMYesteD.Thyroid function in seventy-five healthy preterm infants thirty to thirty-five weeks of gestational age: a prospective and longitudinal study during the first year of life. Thyroid200414435–442. (https://doi.org/10.1089/105072504323150741)
HymanSJGreigFHolzmanIPatelAWallachERapaportR.Late rise of thyroid stimulating hormone in ill newborns. Journal of Pediatric Endocrinology and Metabolism200720501–510. (https://doi.org/10.1515/JPEM.2007.20.4.501)
BijarniaSWilckenBWileyVC. Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test. Journal of Inherited Metabolic Disease201134827–833. (https://doi.org/10.1007/s10545-011-9286-8)
ZungAYehieliABlauAAlmashanuS. Characteristics of delayed thyroid-stimulating hormone elevation in neonatal intensive care unit newborns. Journal of Pediatrics2016178135–140. (https://doi.org/10.1016/j.jpeds.2016.07.022)
CavarzerePCamilotMPopaFILauriolaSTeofoliFGaudinoRVincenziMAntoniazziF.Congenital hypothyroidism with delayed TSH elevation in low-birth-weight infants: incidence, diagnosis and management. European Journal of Endocrinology2016175395–402. (https://doi.org/10.1530/EJE-15-1233)
HeatherNLHofmanPLde HoraMCarllJDerraikJGWebsterD.Evaluation of the revised New Zealand national newborn screening protocol for congenital hypothyroidism. Clinical Endocrinology201686431–437. (https://doi.org/10.1111/cen.13250)
SilvaSAChagasAJGoulartEMSilvaGAMarçalLVGomesMNAlvesVM.Screening for congenital hypothyroidism in extreme premature and/or very low birth weight newborns: the importance of a specific protocol. Journal of Pediatric Endocrinology and Metabolism20102345–52. (https://doi.org/10.1515/JPEM.2010.23.1-2.45)
HadlowNCRothackerKMWardropRBrownSJLimEMWalshJP. The relationship between TSH and free T4 in a large population is complex and nonlinear and differs by age and sex. Journal of Clinical Endocrinology and Metabolism2013982936–2943. (https://doi.org/10.1210/jc.2012-4223)
DavyTDanemanDWalfishPGEhrlichRM. Congenital hypothyroidism: the effect of stopping treatment at 3 years of age. American Journal of Diseases of Children19851391028–1030. (https://doi.org/10.1001/archpedi.1985.02140120074031)
HintonCFHarrisKBBorgfeldLDrummond-BorgMEatonRLoreyFTherrellBLWallaceJPassKA. Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics2010125 (Supplement 2) S37–S47. (https://doi.org/10.1542/peds.2009-1975D)
PollittRJ.Evidence or enthusiasm? Why yields from UK newborn screening programmes for congenital hypothyroidism are increasing. Archives of Disease in Childhood2016101120–123. (https://doi.org/10.1136/archdischild-2015-309546)
ParksJSLinMGrosseSDHintonCFDrummond-BorgMBorgfeldLSullivanKM.The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics2010125 (Supplement 2) S54–S63. (https://doi.org/10.1542/peds.2009-1975F)